Oncology Targeting Peptide Library
Oncology Targeting Peptide Library
Oncology Targeting Peptide Library is a specialized peptide discovery resource designed to support precision oncology research and targeted therapeutic development. In modern cancer treatment, improving selectivity toward tumor tissues while minimizing off-target toxicity remains a central challenge. Peptide-based targeting ligands have emerged as a powerful solution due to their relatively small size, high tissue penetration capability, flexible chemical modifiability, and generally low immunogenicity compared with antibodies.
This library consists of structurally diverse peptide sequences engineered and curated to interact with tumor-associated biomarkers, including surface receptors, extracellular matrix components, and tumor microenvironment-related targets. It enables systematic exploration of peptide–target interactions across multiple cancer types and disease models.
Target Diversity and Screening Strategy
A key strength of the Oncology Targeting Peptide Library lies in its broad target coverage. It is designed to support discovery across multiple tumor indications, including solid tumors and hematological malignancies. The library is applicable to targets such as receptor tyrosine kinases, integrins, tumor-specific antigens, and microenvironmental markers associated with angiogenesis and metastasis.
High-throughput screening workflows are employed to evaluate peptide binding performance across diverse cancer cell lines and biological models. Screening outputs typically include binding affinity, receptor selectivity, cellular uptake efficiency, and internalization behavior. This multi-parameter evaluation ensures that selected peptides are not only strong binders in vitro but also functionally relevant in biologically complex tumor environments.
